CHINA Trends and Developments
Trends and Developments Contributed by: Min Zhu, Ya-ling (Michelle) Gon, Yang (Aaron) Gu, Chai Lu, Ying Li and Shiye Yuan Han Kun Law Offices
Han Kun Law Offices is a leading full-service law firm in China with over 900 professionals located in Beijing, Shanghai, Shenzhen, Hong Kong, Haikou, Wuhan, Singapore, New York City and Silicon Val- ley. The firm’s main practice areas include private equity, mergers and acquisitions, international and domestic capital markets, investment funds, as- set management, compliance, banking and finance, aviation finance, foreign direct investment, antitrust/ competition, data protection, private client/wealth
management, intellectual property, bankruptcy and restructuring, and dispute resolution. Han Kun pro- vides a full range of legal services and business ad- vice to Chinese companies and multinationals doing business in China. Over the years, Han Kun has been widely recognised as a leader in complex cross-bor- der, domestic transactions and compliance matters that cover foreign investment access, industry com- pliance, labour and national security review, taxation, foreign exchange and intellectual property.
Authors
Min Zhu has extensive legal practice experience in the life sciences and healthcare industries. He has served life sciences and healthcare companies in different stages of development, including financing and
sciences, healthcare, agriculture, food-related products, wine and spirits, hospitality, cruise lines, manufacturing, IT and high tech.
Yang (Aaron) Gu focuses on corporate, regulatory compliance, and transactional services for the life sciences, biopharmaceutical, medical and healthcare industries, including biosecurity and human genetic
licensing deals for start-ups, mergers and acquisitions, and various regulatory and compliance matters, such as anti-corruption and anti-bribery, clinical trials, drug and medical device registration, distribution, advertising and promotion, as well as medical and healthcare data compliance. Prior to joining Han Kun, Mr Zhu practised law for many years at another leading Chinese firm and in the Shanghai office of an international law firm.
resource issues, clinical trial matters, product marketing authorisations, GxP compliance, drug licensing and collaboration, as well as regulatory issues involved in venture capital and private equity investments, M&A, and foreign and outbound investments in the life sciences industries. Mr Gu also provides advocacy advice on draft laws and regulations released by the NMPA and other Chinese governmental authorities.
Ya-ling (Michelle) Gon focuses her practice on representing clients in complicated and challenging compliance and regulatory matters, including anti-corruption, unfair competition, anti-monopoly, anti-
Chai Lu focuses her practice on public and private mergers and acquisitions (M&A) transactions, private equity transactions, securities offerings, and exchange listings. She has advised a number of clients in
fraud, export control and trade sanction areas. Ms Gon is well respected for being personally devoted to her clients and offering practical advice on resolving complex legal issues. Most of Ms Gon’s clients are leading multinationals doing business in China or large China-based multinationals doing business globally across a wide range of industries, including pharmaceuticals, medical devices, life
Greater China on cross-border M&A, SEC-registered and non-registered securities offerings, and listings on the Stock Exchange of Hong Kong. She also advises clients on ongoing regulatory and reporting
75 CHAMBERS.COM
Powered by FlippingBook